| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.48e-13 | 16 | 38 | 6 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.67e-12 | 21 | 38 | 6 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.23e-08 | 85 | 38 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 5.28e-08 | 20 | 38 | 4 | GO:0034185 | |
| GeneOntologyMolecularFunction | calcium ion binding | 9.16e-08 | 749 | 38 | 11 | GO:0005509 | |
| GeneOntologyMolecularFunction | reelin receptor activity | 3.53e-06 | 2 | 38 | 2 | GO:0038025 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 2.11e-05 | 4 | 38 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.74e-05 | 188 | 38 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 3.99e-05 | 35 | 38 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 3.99e-05 | 35 | 38 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | fibronectin binding | 5.12e-05 | 38 | 38 | 3 | GO:0001968 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.24e-04 | 51 | 38 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.47e-04 | 268 | 38 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | retromer complex binding | 1.57e-04 | 10 | 38 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.15e-04 | 156 | 38 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | cytokine binding | 2.20e-04 | 157 | 38 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | integrin binding | 3.33e-04 | 175 | 38 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.48e-04 | 323 | 38 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | protease binding | 3.79e-04 | 181 | 38 | 4 | GO:0002020 | |
| GeneOntologyMolecularFunction | heparin binding | 4.74e-04 | 192 | 38 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | collagen binding | 4.90e-04 | 81 | 38 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 8.70e-04 | 23 | 38 | 2 | GO:0010314 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 9.59e-04 | 102 | 38 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.11e-03 | 26 | 38 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 1.39e-03 | 29 | 38 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 1.58e-03 | 31 | 38 | 2 | GO:0080025 | |
| GeneOntologyMolecularFunction | laminin binding | 1.90e-03 | 34 | 38 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 2.02e-03 | 35 | 38 | 2 | GO:0043325 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 2.13e-03 | 36 | 38 | 2 | GO:0070273 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 2.50e-03 | 39 | 38 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 3.03e-03 | 43 | 38 | 2 | GO:0061650 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 3.76e-03 | 48 | 38 | 2 | GO:0032266 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 3.92e-03 | 49 | 38 | 2 | GO:0005547 | |
| GeneOntologyMolecularFunction | kinesin binding | 4.91e-03 | 55 | 38 | 2 | GO:0019894 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 5.60e-03 | 190 | 38 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | structural molecule activity | 6.31e-03 | 891 | 38 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 7.09e-03 | 207 | 38 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 7.57e-03 | 212 | 38 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | coreceptor activity | 8.29e-03 | 72 | 38 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 8.51e-03 | 73 | 38 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 8.51e-03 | 73 | 38 | 2 | GO:0001786 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 8.78e-03 | 430 | 38 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.14e-02 | 85 | 38 | 2 | GO:0019199 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 1.27e-02 | 90 | 38 | 2 | GO:0030971 | |
| GeneOntologyBiologicalProcess | endocytosis | 1.73e-06 | 827 | 38 | 10 | GO:0006897 | |
| GeneOntologyBiologicalProcess | import into cell | LRP1 LRP2 LRP4 VLDLR LRP12 THBS1 ATG3 LRP1B KCNJ14 LRP8 GAS6 | 2.38e-06 | 1074 | 38 | 11 | GO:0098657 |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 5.48e-06 | 19 | 38 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | protein processing | 1.26e-05 | 285 | 38 | 6 | GO:0016485 | |
| GeneOntologyBiologicalProcess | protein maturation | 1.39e-05 | 619 | 38 | 8 | GO:0051604 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.47e-05 | 883 | 38 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 3.29e-05 | 5 | 38 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 3.29e-05 | 5 | 38 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 5.44e-05 | 40 | 38 | 3 | GO:0097242 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 6.90e-05 | 7 | 38 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 7.25e-05 | 44 | 38 | 3 | GO:0006958 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 8.75e-05 | 802 | 38 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | reelin-mediated signaling pathway | 9.19e-05 | 8 | 38 | 2 | GO:0038026 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 9.19e-05 | 8 | 38 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 9.42e-05 | 48 | 38 | 3 | GO:0043277 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.01e-04 | 819 | 38 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.07e-04 | 826 | 38 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.31e-04 | 850 | 38 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 2.02e-04 | 62 | 38 | 3 | GO:0002455 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 2.16e-04 | 12 | 38 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.51e-04 | 1194 | 38 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | complement activation | 2.90e-04 | 70 | 38 | 3 | GO:0006956 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 2.97e-04 | 14 | 38 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | chemotaxis | 3.36e-04 | 517 | 38 | 6 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 3.43e-04 | 519 | 38 | 6 | GO:0042330 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 3.79e-04 | 748 | 38 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | neuron projection development | 4.32e-04 | 1285 | 38 | 9 | GO:0031175 | |
| GeneOntologyBiologicalProcess | negative regulation of focal adhesion assembly | 4.42e-04 | 17 | 38 | 2 | GO:0051895 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate junction organization | 4.42e-04 | 17 | 38 | 2 | GO:0150118 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 4.71e-04 | 198 | 38 | 4 | GO:0048813 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 5.87e-04 | 89 | 38 | 3 | GO:0001523 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 6.47e-04 | 92 | 38 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 6.74e-04 | 1366 | 38 | 9 | GO:0051130 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 6.89e-04 | 94 | 38 | 3 | GO:0003151 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 6.89e-04 | 94 | 38 | 3 | GO:0016101 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite development | 7.46e-04 | 22 | 38 | 2 | GO:1900006 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 8.89e-04 | 24 | 38 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | transcytosis | 8.89e-04 | 24 | 38 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 9.50e-04 | 105 | 38 | 3 | GO:0006721 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte chemotaxis | 1.06e-03 | 109 | 38 | 3 | GO:0002690 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 1.08e-03 | 1458 | 38 | 9 | GO:0051247 | |
| GeneOntologyBiologicalProcess | neuron development | 1.10e-03 | 1463 | 38 | 9 | GO:0048666 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 1.21e-03 | 28 | 38 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | plasminogen activation | 1.21e-03 | 28 | 38 | 2 | GO:0031639 | |
| GeneOntologyBiologicalProcess | outflow tract septum morphogenesis | 1.21e-03 | 28 | 38 | 2 | GO:0003148 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 1.21e-03 | 28 | 38 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | regulation of renal system process | 1.21e-03 | 28 | 38 | 2 | GO:0098801 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.22e-03 | 1186 | 38 | 8 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 1.24e-03 | 1189 | 38 | 8 | GO:0044087 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.28e-03 | 445 | 38 | 5 | GO:0141091 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 1.30e-03 | 29 | 38 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 1.30e-03 | 29 | 38 | 2 | GO:0003417 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 1.49e-03 | 31 | 38 | 2 | GO:0034315 | |
| GeneOntologyBiologicalProcess | growth | 1.58e-03 | 1235 | 38 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | phagocytosis | 1.58e-03 | 274 | 38 | 4 | GO:0006909 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.58e-03 | 32 | 38 | 2 | GO:0048266 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.61e-03 | 126 | 38 | 3 | GO:0033555 | |
| GeneOntologyBiologicalProcess | protein localization to endosome | 1.68e-03 | 33 | 38 | 2 | GO:0036010 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 1.72e-03 | 129 | 38 | 3 | GO:0141061 | |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 1.72e-03 | 129 | 38 | 3 | GO:0031640 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.79e-03 | 974 | 38 | 7 | GO:0034330 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.81e-03 | 482 | 38 | 5 | GO:0007178 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 1.83e-03 | 132 | 38 | 3 | GO:0141060 | |
| GeneOntologyBiologicalProcess | artery development | 1.87e-03 | 133 | 38 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.92e-03 | 134 | 38 | 3 | GO:0003279 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 1.94e-03 | 724 | 38 | 6 | GO:0001934 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 2.00e-03 | 136 | 38 | 3 | GO:0050764 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte chemotaxis | 2.30e-03 | 143 | 38 | 3 | GO:0002688 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 2.35e-03 | 39 | 38 | 2 | GO:0003416 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 2.35e-03 | 144 | 38 | 3 | GO:0006720 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 2.44e-03 | 309 | 38 | 4 | GO:1901888 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 2.54e-03 | 148 | 38 | 3 | GO:0006986 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 2.56e-03 | 313 | 38 | 4 | GO:0099173 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 2.59e-03 | 41 | 38 | 2 | GO:1901889 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 2.59e-03 | 41 | 38 | 2 | GO:0051125 | |
| GeneOntologyCellularComponent | membrane attack complex | 1.93e-07 | 7 | 38 | 3 | GO:0005579 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.33e-05 | 80 | 38 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | pore complex | 1.40e-05 | 26 | 38 | 3 | GO:0046930 | |
| GeneOntologyCellularComponent | cell surface | 1.32e-04 | 1111 | 38 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | WASH complex | 3.33e-04 | 15 | 38 | 2 | GO:0071203 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.58e-04 | 530 | 38 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | receptor complex | 5.82e-04 | 581 | 38 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.09e-03 | 656 | 38 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.11e-03 | 658 | 38 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.28e-03 | 451 | 38 | 5 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.63e-03 | 477 | 38 | 5 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.06e-03 | 503 | 38 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.36e-03 | 519 | 38 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.44e-03 | 523 | 38 | 5 | GO:0098984 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.72e-03 | 785 | 38 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | axonal growth cone | 3.03e-03 | 45 | 38 | 2 | GO:0044295 | |
| HumanPheno | Decreased circulating terminal complement component concentration | 5.06e-07 | 6 | 16 | 3 | HP:0033057 | |
| Domain | Ldl_recept_a | LRP1 LRP2 LRP4 CORIN VLDLR TMPRSS9 LRP12 C7 C8A C9 SSPOP LRP1B ST14 LRP8 | 2.17e-28 | 45 | 38 | 14 | PF00057 |
| Domain | - | LRP1 LRP2 LRP4 CORIN VLDLR TMPRSS9 LRP12 C7 C8A C9 SSPOP LRP1B ST14 LRP8 | 3.11e-28 | 46 | 38 | 14 | 4.10.400.10 |
| Domain | LDLRA_1 | LRP1 LRP2 LRP4 CORIN VLDLR TMPRSS9 LRP12 C7 C8A C9 SSPOP LRP1B ST14 LRP8 | 6.24e-28 | 48 | 38 | 14 | PS01209 |
| Domain | LDrepeatLR_classA_rpt | LRP1 LRP2 LRP4 CORIN VLDLR TMPRSS9 LRP12 C7 C8A C9 SSPOP LRP1B ST14 LRP8 | 8.73e-28 | 49 | 38 | 14 | IPR002172 |
| Domain | LDLa | LRP1 LRP2 LRP4 CORIN VLDLR TMPRSS9 LRP12 C7 C8A C9 SSPOP LRP1B ST14 LRP8 | 8.73e-28 | 49 | 38 | 14 | SM00192 |
| Domain | LDLRA_2 | LRP1 LRP2 LRP4 CORIN VLDLR TMPRSS9 LRP12 C7 C8A C9 SSPOP LRP1B ST14 LRP8 | 8.73e-28 | 49 | 38 | 14 | PS50068 |
| Domain | LDLR_class-A_CS | LRP1 LRP2 LRP4 CORIN VLDLR LRP12 C7 C8A C9 SSPOP LRP1B ST14 LRP8 | 1.17e-26 | 40 | 38 | 13 | IPR023415 |
| Domain | EGF_3 | LRP1 LRP2 LRP4 VLDLR THBS1 THBS4 ADAM19 C7 C8A COMP C9 SSPOP LTBP4 LRP1B LRP8 GAS6 | 4.10e-21 | 235 | 38 | 16 | PS50026 |
| Domain | EGF_1 | LRP1 LRP2 LRP4 VLDLR THBS1 THBS4 ADAM19 C7 C8A COMP C9 SSPOP LTBP4 LRP1B LRP8 GAS6 | 1.55e-20 | 255 | 38 | 16 | PS00022 |
| Domain | EGF_2 | LRP1 LRP2 LRP4 VLDLR THBS1 THBS4 ADAM19 C7 C8A COMP C9 SSPOP LTBP4 LRP1B LRP8 GAS6 | 2.88e-20 | 265 | 38 | 16 | PS01186 |
| Domain | EGF-like_dom | LRP1 LRP2 LRP4 VLDLR THBS1 THBS4 ADAM19 C7 C8A COMP C9 LTBP4 LRP1B LRP8 GAS6 | 5.76e-19 | 249 | 38 | 15 | IPR000742 |
| Domain | EGF-like_CS | LRP1 LRP2 LRP4 VLDLR THBS1 THBS4 ADAM19 C7 C8A COMP C9 LTBP4 LRP1B LRP8 GAS6 | 1.17e-18 | 261 | 38 | 15 | IPR013032 |
| Domain | EGF_CA | 1.11e-17 | 86 | 38 | 11 | PF07645 | |
| Domain | Growth_fac_rcpt_ | LRP1 LRP2 LRP4 VLDLR THBS4 C8A COMP C9 LTBP4 LRP1B LRP8 GAS6 | 1.69e-16 | 156 | 38 | 12 | IPR009030 |
| Domain | EGF_CA | 6.05e-16 | 122 | 38 | 11 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.27e-16 | 124 | 38 | 11 | IPR001881 | |
| Domain | EGF_Ca-bd_CS | 3.72e-15 | 97 | 38 | 10 | IPR018097 | |
| Domain | EGF_CA | 4.59e-15 | 99 | 38 | 10 | PS01187 | |
| Domain | Ldl_recept_b | 1.39e-13 | 14 | 38 | 6 | PF00058 | |
| Domain | LDLRB | 1.39e-13 | 14 | 38 | 6 | PS51120 | |
| Domain | LY | 2.31e-13 | 15 | 38 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.31e-13 | 15 | 38 | 6 | IPR000033 | |
| Domain | EGF | 8.83e-13 | 235 | 38 | 11 | SM00181 | |
| Domain | ASX_HYDROXYL | 2.18e-11 | 100 | 38 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.50e-11 | 106 | 38 | 8 | IPR000152 | |
| Domain | EGF | 1.41e-10 | 126 | 38 | 8 | PF00008 | |
| Domain | - | 1.46e-10 | 39 | 38 | 6 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.14e-10 | 46 | 38 | 6 | IPR011042 | |
| Domain | cEGF | 1.69e-09 | 26 | 38 | 5 | IPR026823 | |
| Domain | cEGF | 1.69e-09 | 26 | 38 | 5 | PF12662 | |
| Domain | TSP3 | 7.75e-08 | 5 | 38 | 3 | PS51234 | |
| Domain | TSP_CTER | 7.75e-08 | 5 | 38 | 3 | PS51236 | |
| Domain | - | 7.75e-08 | 5 | 38 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 7.75e-08 | 5 | 38 | 3 | IPR008859 | |
| Domain | TSP_C | 7.75e-08 | 5 | 38 | 3 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 7.75e-08 | 5 | 38 | 3 | IPR017897 | |
| Domain | TSP_3 | 7.75e-08 | 5 | 38 | 3 | PF02412 | |
| Domain | Thrombospondin_3-like_rpt | 7.75e-08 | 5 | 38 | 3 | IPR003367 | |
| Domain | TSP_type-3_rpt | 7.75e-08 | 5 | 38 | 3 | IPR028974 | |
| Domain | MACPF_CS | 1.55e-07 | 6 | 38 | 3 | IPR020863 | |
| Domain | TSP_1 | 1.71e-07 | 63 | 38 | 5 | PF00090 | |
| Domain | TSP1 | 2.00e-07 | 65 | 38 | 5 | SM00209 | |
| Domain | TSP1_rpt | 2.00e-07 | 65 | 38 | 5 | IPR000884 | |
| Domain | TSP1 | 2.00e-07 | 65 | 38 | 5 | PS50092 | |
| Domain | MACPF_2 | 2.70e-07 | 7 | 38 | 3 | PS51412 | |
| Domain | MACPF_1 | 2.70e-07 | 7 | 38 | 3 | PS00279 | |
| Domain | MAC_perforin | 9.23e-07 | 10 | 38 | 3 | IPR001862 | |
| Domain | MACPF | 1.27e-06 | 11 | 38 | 3 | PF01823 | |
| Domain | MACPF | 1.69e-06 | 12 | 38 | 3 | SM00457 | |
| Domain | MACPF | 1.69e-06 | 12 | 38 | 3 | IPR020864 | |
| Domain | DUF5050 | 4.03e-06 | 2 | 38 | 2 | IPR032485 | |
| Domain | DUF5050 | 4.03e-06 | 2 | 38 | 2 | PF16472 | |
| Domain | FAM21 | 4.03e-06 | 2 | 38 | 2 | IPR027308 | |
| Domain | FAM21/CAPZIP | 1.21e-05 | 3 | 38 | 2 | IPR029341 | |
| Domain | Thbs/COMP_coiled-coil | 1.21e-05 | 3 | 38 | 2 | IPR024665 | |
| Domain | COMP | 1.21e-05 | 3 | 38 | 2 | PF11598 | |
| Domain | CAP-ZIP_m | 1.21e-05 | 3 | 38 | 2 | PF15255 | |
| Domain | - | 4.06e-05 | 95 | 38 | 4 | 2.60.120.200 | |
| Domain | ConA-like_dom | 7.76e-05 | 219 | 38 | 5 | IPR013320 | |
| Domain | CUB | 1.34e-04 | 49 | 38 | 3 | PF00431 | |
| Domain | CUB | 1.43e-04 | 50 | 38 | 3 | SM00042 | |
| Domain | - | 1.60e-04 | 52 | 38 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.70e-04 | 53 | 38 | 3 | PS01180 | |
| Domain | CUB_dom | 2.11e-04 | 57 | 38 | 3 | IPR000859 | |
| Domain | Laminin_G | 2.22e-04 | 58 | 38 | 3 | IPR001791 | |
| Domain | EGF_extracell | 2.45e-04 | 60 | 38 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.45e-04 | 60 | 38 | 3 | PF07974 | |
| Domain | TIL_dom | 3.61e-04 | 14 | 38 | 2 | IPR002919 | |
| Domain | TRYPSIN_SER | 8.08e-04 | 90 | 38 | 3 | IPR033116 | |
| Domain | FA58C | 8.26e-04 | 21 | 38 | 2 | SM00231 | |
| Domain | FA58C_3 | 8.26e-04 | 21 | 38 | 2 | PS50022 | |
| Domain | FA58C_1 | 8.26e-04 | 21 | 38 | 2 | PS01285 | |
| Domain | FA58C_2 | 8.26e-04 | 21 | 38 | 2 | PS01286 | |
| Domain | TSPN | 9.93e-04 | 23 | 38 | 2 | SM00210 | |
| Domain | F5_F8_type_C | 1.08e-03 | 24 | 38 | 2 | PF00754 | |
| Domain | FA58C | 1.08e-03 | 24 | 38 | 2 | IPR000421 | |
| Domain | TRYPSIN_HIS | 1.19e-03 | 103 | 38 | 3 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.30e-03 | 106 | 38 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.33e-03 | 107 | 38 | 3 | PS00134 | |
| Domain | Peptidase_S1A | 1.56e-03 | 113 | 38 | 3 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.64e-03 | 115 | 38 | 3 | PS50240 | |
| Domain | Tryp_SPc | 1.72e-03 | 117 | 38 | 3 | SM00020 | |
| Domain | Trypsin | 1.90e-03 | 121 | 38 | 3 | PF00089 | |
| Domain | Trypsin_dom | 1.90e-03 | 121 | 38 | 3 | IPR001254 | |
| Domain | Peptidase_S1_PA | 1.99e-03 | 123 | 38 | 3 | IPR009003 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 3.35e-07 | 7 | 31 | 3 | M47873 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 5.35e-07 | 8 | 31 | 3 | MM14656 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 5.35e-07 | 8 | 31 | 3 | M27006 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 8.02e-07 | 9 | 31 | 3 | M47881 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 8.02e-07 | 9 | 31 | 3 | M22072 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.95e-06 | 96 | 31 | 5 | M39581 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 2.09e-06 | 12 | 31 | 3 | M48316 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.68e-06 | 45 | 31 | 4 | MM15344 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.71e-06 | 13 | 31 | 3 | M4732 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.48e-06 | 48 | 31 | 4 | M27642 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 4.30e-06 | 15 | 31 | 3 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 6.41e-06 | 17 | 31 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.07e-05 | 20 | 31 | 3 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 1.44e-05 | 22 | 31 | 3 | M39502 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.50e-05 | 381 | 31 | 7 | M48063 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 4.67e-05 | 92 | 31 | 4 | MM14881 | |
| Pathway | KEGG_PRION_DISEASES | 6.01e-05 | 35 | 31 | 3 | M13036 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 6.47e-05 | 100 | 31 | 4 | M27158 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 8.13e-05 | 106 | 31 | 4 | M42535 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.76e-05 | 7 | 31 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.76e-05 | 7 | 31 | 2 | M22049 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 1.30e-04 | 8 | 31 | 2 | MM1582 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.54e-04 | 11 | 31 | 2 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.05e-04 | 12 | 31 | 2 | MM1368 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 3.60e-04 | 13 | 31 | 2 | M42551 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.55e-04 | 300 | 31 | 5 | M610 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 4.57e-04 | 69 | 31 | 3 | M16894 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 6.24e-04 | 17 | 31 | 2 | MM1369 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 7.42e-04 | 189 | 31 | 4 | MM14772 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 7.57e-04 | 190 | 31 | 4 | MM15687 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 8.13e-04 | 84 | 31 | 3 | MM14653 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 8.13e-04 | 84 | 31 | 3 | M7098 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 8.71e-04 | 86 | 31 | 3 | M2642 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 8.83e-04 | 198 | 31 | 4 | M18311 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 9.62e-04 | 89 | 31 | 3 | M39398 | |
| Pathway | PID_LIS1_PATHWAY | 1.71e-03 | 28 | 31 | 2 | M163 | |
| Pathway | PID_REELIN_PATHWAY | 1.71e-03 | 28 | 31 | 2 | M69 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.01e-03 | 115 | 31 | 3 | M19752 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.34e-03 | 258 | 31 | 4 | MM14572 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-03 | 39 | 31 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.30e-03 | 39 | 31 | 2 | MM15165 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | 3.45e-03 | 139 | 31 | 3 | M4741 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 3.81e-03 | 42 | 31 | 2 | M174 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 7.12e-14 | 21 | 39 | 6 | 21337463 | |
| Pubmed | 1.15e-11 | 18 | 39 | 5 | 10827173 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 12169628 | ||
| Pubmed | 4.43e-10 | 11 | 39 | 4 | 24639464 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.34e-09 | 14 | 39 | 4 | 17389516 | |
| Pubmed | 1.34e-09 | 14 | 39 | 4 | 15082773 | ||
| Pubmed | 5.21e-09 | 4 | 39 | 3 | 7775583 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 30622267 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 16101684 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 18467703 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 10551839 | ||
| Pubmed | Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration. | 1.30e-08 | 5 | 39 | 3 | 18946489 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 19047013 | ||
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 18685438 | ||
| Pubmed | 1.68e-08 | 71 | 39 | 5 | 33541421 | ||
| Pubmed | Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. | 2.60e-08 | 6 | 39 | 3 | 22832194 | |
| Pubmed | CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. | 4.55e-08 | 7 | 39 | 3 | 30552328 | |
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 10380922 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 7.27e-08 | 8 | 39 | 3 | 24460873 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 9.95e-08 | 101 | 39 | 5 | 23382219 | |
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 23986861 | ||
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 20005821 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20827171 | ||
| Pubmed | CspA from Borrelia burgdorferi inhibits the terminal complement pathway. | 1.23e-06 | 2 | 39 | 2 | 23943762 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21601501 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.23e-06 | 2 | 39 | 2 | 15963947 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 34445520 | ||
| Pubmed | Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice. | 1.23e-06 | 2 | 39 | 2 | 15327526 | |
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 1.23e-06 | 2 | 39 | 2 | 36717248 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24983516 | ||
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 1.23e-06 | 2 | 39 | 2 | 12871934 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 4063341 | ||
| Pubmed | Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites. | 1.23e-06 | 2 | 39 | 2 | 16148025 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15847701 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 34929721 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8350346 | ||
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 1.23e-06 | 2 | 39 | 2 | 30464261 | |
| Pubmed | Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix. | 1.23e-06 | 2 | 39 | 2 | 25995382 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 9045712 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 30873003 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 18301736 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17154366 | ||
| Pubmed | The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. | 1.23e-06 | 2 | 39 | 2 | 17261317 | |
| Pubmed | Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states. | 1.23e-06 | 2 | 39 | 2 | 22745497 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 14991768 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29336258 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24877199 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25393517 | ||
| Pubmed | Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit. | 1.23e-06 | 2 | 39 | 2 | 12463754 | |
| Pubmed | Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome. | 1.23e-06 | 2 | 39 | 2 | 24086667 | |
| Pubmed | Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb. | 3.67e-06 | 3 | 39 | 2 | 23209795 | |
| Pubmed | Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region. | 3.67e-06 | 3 | 39 | 2 | 18285447 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 20427281 | ||
| Pubmed | Functional importance of covalent homodimer of reelin protein linked via its central region. | 3.67e-06 | 3 | 39 | 2 | 21844191 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11931574 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18277139 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18032585 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 25976449 | ||
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 3.67e-06 | 3 | 39 | 2 | 24251389 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 28123028 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11920707 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15950758 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 21507937 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23083738 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18039658 | ||
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 3.67e-06 | 3 | 39 | 2 | 33910854 | |
| Pubmed | Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. | 3.67e-06 | 3 | 39 | 2 | 12670700 | |
| Pubmed | Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair. | 3.67e-06 | 3 | 39 | 2 | 38147128 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18778775 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18178577 | ||
| Pubmed | Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. | 3.67e-06 | 3 | 39 | 2 | 18174160 | |
| Pubmed | Contributions of VLDLR and LRP8 in the establishment of retinogeniculate projections. | 3.67e-06 | 3 | 39 | 2 | 23758727 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12807892 | ||
| Pubmed | The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1). | 3.67e-06 | 3 | 39 | 2 | 24076391 | |
| Pubmed | ApoER2 function in the establishment and maintenance of retinal synaptic connectivity. | 3.67e-06 | 3 | 39 | 2 | 21976526 | |
| Pubmed | Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. | 3.67e-06 | 3 | 39 | 2 | 18653767 | |
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 3.67e-06 | 3 | 39 | 2 | 12482844 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 22170052 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 25712208 | ||
| Pubmed | Reelin and its receptors, VLDLR and ApoER2, in melanocytic nevi. | 3.67e-06 | 3 | 39 | 2 | 28255385 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 3.67e-06 | 3 | 39 | 2 | 26168731 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18367731 | ||
| Pubmed | 3.74e-06 | 27 | 39 | 3 | 24586749 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 5.73e-06 | 31 | 39 | 3 | 31550482 | |
| Pubmed | 6.32e-06 | 32 | 39 | 3 | 18842294 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 12220191 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16481437 | ||
| Pubmed | Disabled1 regulates the intracellular trafficking of reelin receptors. | 7.34e-06 | 4 | 39 | 2 | 15718228 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 23506116 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10571240 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 10571241 | ||
| Pubmed | Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. | 7.34e-06 | 4 | 39 | 2 | 12167620 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 23651543 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 14724251 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 12687696 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 7.34e-06 | 4 | 39 | 2 | 6338048 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 11421580 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17548821 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15863833 | ||
| Pubmed | Expression and regulation of reelin and its receptors in the enteric nervous system. | 7.34e-06 | 4 | 39 | 2 | 24844606 | |
| Interaction | ZFP41 interactions | 1.01e-09 | 57 | 38 | 6 | int:ZFP41 | |
| Interaction | CLU interactions | 1.52e-08 | 245 | 38 | 8 | int:CLU | |
| Interaction | MAPK8IP1 interactions | 7.73e-08 | 58 | 38 | 5 | int:MAPK8IP1 | |
| Interaction | ANKRD36B interactions | 9.18e-08 | 60 | 38 | 5 | int:ANKRD36B | |
| Interaction | NTN5 interactions | 1.11e-07 | 24 | 38 | 4 | int:NTN5 | |
| Interaction | IGFL3 interactions | 2.84e-07 | 75 | 38 | 5 | int:IGFL3 | |
| Interaction | LRPAP1 interactions | 1.02e-06 | 180 | 38 | 6 | int:LRPAP1 | |
| Interaction | ZNF563 interactions | 1.34e-06 | 12 | 38 | 3 | int:ZNF563 | |
| Interaction | MAPK8IP2 interactions | 2.39e-06 | 115 | 38 | 5 | int:MAPK8IP2 | |
| Interaction | SCN3A interactions | 3.41e-06 | 16 | 38 | 3 | int:SCN3A | |
| Interaction | ZDHHC15 interactions | 3.61e-06 | 125 | 38 | 5 | int:ZDHHC15 | |
| Interaction | ZNF224 interactions | 6.90e-06 | 20 | 38 | 3 | int:ZNF224 | |
| Interaction | ZNF408 interactions | 7.46e-06 | 145 | 38 | 5 | int:ZNF408 | |
| Interaction | ANAPC10 interactions | 8.02e-06 | 68 | 38 | 4 | int:ANAPC10 | |
| Interaction | SNX17 interactions | 1.61e-05 | 81 | 38 | 4 | int:SNX17 | |
| Interaction | APOE interactions | 1.66e-05 | 171 | 38 | 5 | int:APOE | |
| Interaction | FEZF1 interactions | 1.96e-05 | 28 | 38 | 3 | int:FEZF1 | |
| Interaction | ZNF517 interactions | 2.18e-05 | 29 | 38 | 3 | int:ZNF517 | |
| Interaction | ITGB1BP1 interactions | 3.25e-05 | 33 | 38 | 3 | int:ITGB1BP1 | |
| Interaction | TCEANC2 interactions | 3.55e-05 | 34 | 38 | 3 | int:TCEANC2 | |
| Interaction | LPL interactions | 3.88e-05 | 35 | 38 | 3 | int:LPL | |
| Interaction | DAB1 interactions | 4.82e-05 | 107 | 38 | 4 | int:DAB1 | |
| Interaction | VLDLR interactions | 5.39e-05 | 39 | 38 | 3 | int:VLDLR | |
| Interaction | C5 interactions | 5.82e-05 | 40 | 38 | 3 | int:C5 | |
| Interaction | CCN2 interactions | 5.82e-05 | 40 | 38 | 3 | int:CCN2 | |
| Interaction | WASH3P interactions | 6.27e-05 | 41 | 38 | 3 | int:WASH3P | |
| Interaction | SULF2 interactions | 7.30e-05 | 119 | 38 | 4 | int:SULF2 | |
| Interaction | CFC1 interactions | 9.12e-05 | 126 | 38 | 4 | int:CFC1 | |
| Interaction | APBA2 interactions | 1.01e-04 | 48 | 38 | 3 | int:APBA2 | |
| Interaction | FBXO2 interactions | 1.10e-04 | 411 | 38 | 6 | int:FBXO2 | |
| Interaction | C8B interactions | 1.24e-04 | 9 | 38 | 2 | int:C8B | |
| Interaction | SERPINE1 interactions | 1.44e-04 | 54 | 38 | 3 | int:SERPINE1 | |
| Interaction | MYLIP interactions | 1.60e-04 | 56 | 38 | 3 | int:MYLIP | |
| Interaction | SYT2 interactions | 1.79e-04 | 150 | 38 | 4 | int:SYT2 | |
| Interaction | ZNF852 interactions | 1.88e-04 | 11 | 38 | 2 | int:ZNF852 | |
| Interaction | RAB4A interactions | 1.96e-04 | 457 | 38 | 6 | int:RAB4A | |
| Interaction | LRP2 interactions | 1.98e-04 | 154 | 38 | 4 | int:LRP2 | |
| Interaction | ZNF331 interactions | 2.27e-04 | 63 | 38 | 3 | int:ZNF331 | |
| Interaction | PLAT interactions | 2.27e-04 | 63 | 38 | 3 | int:PLAT | |
| Interaction | ATF7 interactions | 2.27e-04 | 63 | 38 | 3 | int:ATF7 | |
| Interaction | HRG interactions | 2.27e-04 | 63 | 38 | 3 | int:HRG | |
| Interaction | CALCR interactions | 2.67e-04 | 13 | 38 | 2 | int:CALCR | |
| Interaction | ZNF248 interactions | 2.67e-04 | 13 | 38 | 2 | int:ZNF248 | |
| Interaction | RNASE4 interactions | 3.11e-04 | 14 | 38 | 2 | int:RNASE4 | |
| Interaction | CUBN interactions | 3.58e-04 | 15 | 38 | 2 | int:CUBN | |
| Interaction | DEFB123 interactions | 4.09e-04 | 16 | 38 | 2 | int:DEFB123 | |
| Interaction | WASH6P interactions | 4.62e-04 | 17 | 38 | 2 | int:WASH6P | |
| Interaction | KLHL25 interactions | 4.62e-04 | 17 | 38 | 2 | int:KLHL25 | |
| Interaction | GALNT3 interactions | 4.62e-04 | 17 | 38 | 2 | int:GALNT3 | |
| Interaction | C9 interactions | 4.62e-04 | 17 | 38 | 2 | int:C9 | |
| Interaction | LRP1 interactions | 4.94e-04 | 196 | 38 | 4 | int:LRP1 | |
| Interaction | DYRK1A interactions | 5.38e-04 | 552 | 38 | 6 | int:DYRK1A | |
| Interaction | LRP1B interactions | 5.49e-04 | 85 | 38 | 3 | int:LRP1B | |
| Interaction | LRP8 interactions | 5.68e-04 | 86 | 38 | 3 | int:LRP8 | |
| Interaction | ST14 interactions | 6.07e-04 | 207 | 38 | 4 | int:ST14 | |
| Interaction | PDGFB interactions | 6.08e-04 | 88 | 38 | 3 | int:PDGFB | |
| Interaction | TIMP3 interactions | 6.49e-04 | 90 | 38 | 3 | int:TIMP3 | |
| Interaction | MDK interactions | 6.70e-04 | 91 | 38 | 3 | int:MDK | |
| Interaction | EGFL6 interactions | 7.11e-04 | 21 | 38 | 2 | int:EGFL6 | |
| Interaction | WASHC1 interactions | 7.37e-04 | 94 | 38 | 3 | int:WASHC1 | |
| Interaction | C8A interactions | 7.81e-04 | 22 | 38 | 2 | int:C8A | |
| Interaction | RAB11A interactions | 8.09e-04 | 830 | 38 | 7 | int:RAB11A | |
| Interaction | FKBP15 interactions | 8.56e-04 | 99 | 38 | 3 | int:FKBP15 | |
| Interaction | TTLL4 interactions | 9.31e-04 | 24 | 38 | 2 | int:TTLL4 | |
| Interaction | DUSP16 interactions | 1.01e-03 | 237 | 38 | 4 | int:DUSP16 | |
| Interaction | SYT1 interactions | 1.02e-03 | 105 | 38 | 3 | int:SYT1 | |
| Interaction | HOOK1 interactions | 1.05e-03 | 240 | 38 | 4 | int:HOOK1 | |
| Interaction | ZNF574 interactions | 1.15e-03 | 246 | 38 | 4 | int:ZNF574 | |
| Interaction | RELN interactions | 1.18e-03 | 27 | 38 | 2 | int:RELN | |
| Interaction | TNFAIP6 interactions | 1.18e-03 | 27 | 38 | 2 | int:TNFAIP6 | |
| Interaction | PID1 interactions | 1.18e-03 | 27 | 38 | 2 | int:PID1 | |
| Interaction | NOS1AP interactions | 1.26e-03 | 113 | 38 | 3 | int:NOS1AP | |
| Interaction | KLRC3 interactions | 1.36e-03 | 29 | 38 | 2 | int:KLRC3 | |
| Interaction | LYZL1 interactions | 1.42e-03 | 118 | 38 | 3 | int:LYZL1 | |
| Interaction | GIPC1 interactions | 1.46e-03 | 119 | 38 | 3 | int:GIPC1 | |
| Interaction | APOH interactions | 1.46e-03 | 30 | 38 | 2 | int:APOH | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 5.54e-04 | 188 | 39 | 3 | chr10q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 4.87e-03 | 122 | 39 | 2 | chr15q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 6.27e-03 | 139 | 39 | 2 | chr5p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 7.73e-03 | 155 | 39 | 2 | chr1p32 | |
| GeneFamily | Low density lipoprotein receptors | 8.97e-18 | 13 | 26 | 7 | 634 | |
| GeneFamily | Complement system|Sushi domain containing | 1.83e-05 | 36 | 26 | 3 | 492 | |
| GeneFamily | WASH complex | 2.97e-05 | 6 | 26 | 2 | 1331 | |
| GeneFamily | Proteases, serine | 9.90e-05 | 63 | 26 | 3 | 738 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.70e-07 | 191 | 39 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.30e-07 | 196 | 39 | 6 | M3008 | |
| Coexpression | HALLMARK_COAGULATION | 1.88e-06 | 138 | 39 | 5 | M5946 | |
| Coexpression | NABA_CORE_MATRISOME | 2.77e-06 | 270 | 39 | 6 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.08e-06 | 275 | 39 | 6 | M5884 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 1.15e-05 | 200 | 39 | 5 | M3584 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN | 3.22e-05 | 6 | 39 | 2 | M14136 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 5.45e-05 | 457 | 39 | 6 | M1613 | |
| Coexpression | MEL18_DN.V1_UP | 5.70e-05 | 141 | 39 | 4 | M2784 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 6.14e-05 | 284 | 39 | 5 | M16975 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 6.36e-05 | 470 | 39 | 6 | MM1053 | |
| Coexpression | NABA_MATRISOME | 9.90e-05 | 1008 | 39 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.12e-04 | 1026 | 39 | 8 | M5889 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.95e-04 | 194 | 39 | 4 | M39122 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN | 1.99e-04 | 76 | 39 | 3 | M8315 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 2.11e-04 | 198 | 39 | 4 | M9534 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 2.15e-04 | 199 | 39 | 4 | M8105 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP | 2.20e-04 | 200 | 39 | 4 | M3705 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 6.34e-07 | 408 | 39 | 8 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 7.03e-05 | 778 | 39 | 8 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 7.44e-05 | 240 | 39 | 5 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.35e-04 | 437 | 39 | 6 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.49e-04 | 445 | 39 | 6 | GSM777043_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.54e-04 | 148 | 39 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 1.64e-04 | 284 | 39 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.91e-04 | 466 | 39 | 6 | GSM777050_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-08 | 196 | 39 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-08 | 196 | 39 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-08 | 196 | 39 | 6 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-08 | 197 | 39 | 6 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-07 | 189 | 39 | 5 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-07 | 189 | 39 | 5 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-07 | 191 | 39 | 5 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-07 | 191 | 39 | 5 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-07 | 191 | 39 | 5 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-07 | 191 | 39 | 5 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-07 | 191 | 39 | 5 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-07 | 191 | 39 | 5 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-07 | 191 | 39 | 5 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-07 | 192 | 39 | 5 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-07 | 192 | 39 | 5 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-07 | 192 | 39 | 5 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 192 | 39 | 5 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.05e-07 | 193 | 39 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.23e-07 | 194 | 39 | 5 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 195 | 39 | 5 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-07 | 195 | 39 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-07 | 195 | 39 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.20e-07 | 199 | 39 | 5 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-07 | 199 | 39 | 5 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 9.89e-06 | 154 | 39 | 4 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 171 | 39 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 171 | 39 | 4 | 007f148f4611ea1826edfa9f91ced36541ad9f5a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 171 | 39 | 4 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-05 | 172 | 39 | 4 | fb8ab2576b5c38db63573a3bf46b8d9d634c4999 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.60e-05 | 174 | 39 | 4 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 1.71e-05 | 177 | 39 | 4 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-05 | 181 | 39 | 4 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 1.87e-05 | 181 | 39 | 4 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-05 | 182 | 39 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 183 | 39 | 4 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.99e-05 | 184 | 39 | 4 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.99e-05 | 184 | 39 | 4 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 185 | 39 | 4 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 185 | 39 | 4 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 185 | 39 | 4 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 2.03e-05 | 185 | 39 | 4 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 186 | 39 | 4 | ca5e9c6531cb5d199e27509bfab1d62e3937177e | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 186 | 39 | 4 | 1ed71b229f40a680071b14f5a7a19706e0fd14b1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 186 | 39 | 4 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 186 | 39 | 4 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-05 | 186 | 39 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.17e-05 | 188 | 39 | 4 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 189 | 39 | 4 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 189 | 39 | 4 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 189 | 39 | 4 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 189 | 39 | 4 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 189 | 39 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.21e-05 | 189 | 39 | 4 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 189 | 39 | 4 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 189 | 39 | 4 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 189 | 39 | 4 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 189 | 39 | 4 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 190 | 39 | 4 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-05 | 190 | 39 | 4 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-05 | 190 | 39 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-05 | 190 | 39 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 191 | 39 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.30e-05 | 191 | 39 | 4 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 191 | 39 | 4 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | b5210de890d338602857b5907135705a507bc2b0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | 0b3dbbc35d9970d3c749aef16dda59886b960e3d | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | c715bbdbbf1482aad45a50a16d5232fd35a9a0bb | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 191 | 39 | 4 | 243d83cbfcc4996ad087ec6386e559e0b8662004 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | c09966f4d63a739a56db4df7e0e0ee9ecacd21ad | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | df56c3e3bb1aafc1126607f4426554c09c8c40cf | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-05 | 192 | 39 | 4 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | d22c1135867bcb9076435e2c6eb1cc1248990d0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-05 | 192 | 39 | 4 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.35e-05 | 192 | 39 | 4 | b86476037ddf8904c1d8a6b3763af7242c031cf3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-05 | 193 | 39 | 4 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | ac088c8f27b5b1888610e461ff45870ca60da886 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 193 | 39 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 193 | 39 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| Computational | Genes in the cancer module 58. | 2.52e-05 | 21 | 30 | 3 | MODULE_58 | |
| Computational | Complement. | 3.35e-05 | 23 | 30 | 3 | MODULE_130 | |
| Computational | Metal / Ca ion binding. | 4.78e-04 | 133 | 30 | 4 | MODULE_324 | |
| Drug | monatepil | 1.30e-09 | 29 | 39 | 5 | CID000060810 | |
| Drug | Epi Lovastatin | 9.58e-08 | 341 | 39 | 8 | CID000003962 | |
| Drug | probucol | 3.18e-07 | 162 | 39 | 6 | CID000004912 | |
| Drug | pitavastatin | 1.45e-06 | 114 | 39 | 5 | CID005282451 | |
| Drug | Chr 5 | 2.28e-06 | 125 | 39 | 5 | CID006448119 | |
| Drug | ezetimibe | 5.06e-06 | 147 | 39 | 5 | CID000150311 | |
| Drug | sterol | 5.55e-06 | 265 | 39 | 6 | CID000001107 | |
| Drug | 25-hydroxycholesterol | 7.64e-06 | 160 | 39 | 5 | CID000065094 | |
| Drug | vitamin E | 8.78e-06 | 441 | 39 | 7 | CID000002116 | |
| Drug | fenoxycarb | 1.06e-05 | 80 | 39 | 4 | CID000051605 | |
| Drug | mangrove | 1.29e-05 | 468 | 39 | 7 | CID000000965 | |
| Drug | tetrahydroaldosterone-3-glucuronide | 1.65e-05 | 29 | 39 | 3 | CID000167918 | |
| Drug | N,N-dibenzylphenylethanolamine | 1.71e-05 | 4 | 39 | 2 | CID000048896 | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.85e-05 | 192 | 39 | 5 | 4288_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | 1.89e-05 | 193 | 39 | 5 | 2675_DN | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.89e-05 | 193 | 39 | 5 | 4743_UP | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 39 | 5 | 2939_UP | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 3463_UP | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 2704_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 5459_DN | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 5114_UP | |
| Drug | Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 4650_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 4675_UP | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; HL60; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 2486_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 4462_UP | |
| Drug | sodium linoleate | 2.36e-05 | 342 | 39 | 6 | CID000003931 | |
| Drug | simvastatin | 4.92e-05 | 390 | 39 | 6 | CID000054454 | |
| Drug | AC1L1J6H | 4.95e-05 | 236 | 39 | 5 | CID000004889 | |
| Drug | 17alpha-estradiol | 5.03e-05 | 1303 | 39 | 10 | CID000000450 | |
| Drug | AC1L9FMG | 5.97e-05 | 7 | 39 | 2 | CID000444053 | |
| Drug | sodium cholate | 6.31e-05 | 408 | 39 | 6 | CID000000303 | |
| Drug | 2,3-pentanedione | 6.94e-05 | 129 | 39 | 4 | ctd:C013186 | |
| Drug | epicholesterol | 9.07e-05 | 636 | 39 | 7 | CID000000304 | |
| Drug | coprogen | 1.02e-04 | 9 | 39 | 2 | CID006323272 | |
| Drug | Calpain inhibitor I | 1.11e-04 | 280 | 39 | 5 | CID000004332 | |
| Drug | Urokinase | 1.28e-04 | 10 | 39 | 2 | DB00013 | |
| Drug | 25-azacoprostane | 1.28e-04 | 10 | 39 | 2 | CID000162243 | |
| Drug | tesaglitazar | 1.96e-04 | 502 | 39 | 6 | ctd:C501413 | |
| Drug | ethylnylestradiol | 2.10e-04 | 1251 | 39 | 9 | CID000003285 | |
| Drug | troglitazone | 2.52e-04 | 526 | 39 | 6 | CID000005591 | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 2.61e-04 | 182 | 39 | 4 | 1663_DN | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.72e-04 | 184 | 39 | 4 | 2168_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.95e-04 | 188 | 39 | 4 | 5702_UP | |
| Drug | AC1L1C6C | 3.11e-04 | 77 | 39 | 3 | CID000001759 | |
| Drug | 5707885; Down 200; 50uM; PC3; HT_HG-U133A | 3.14e-04 | 191 | 39 | 4 | 6390_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.26e-04 | 193 | 39 | 4 | 3344_UP | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 3.26e-04 | 193 | 39 | 4 | 2129_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 2284_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 4538_UP | |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 3126_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 4502_DN | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 6433_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 4980_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 6626_DN | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 6695_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 4016_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 2475_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 5593_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 7378_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 2280_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 3720_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 3875_UP | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4674_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 3605_UP | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 3399_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; HL60; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 2361_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4186_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 2212_DN | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4198_UP | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; HL60; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 1843_UP | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4555_UP | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4277_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 6727_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 1545_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 6759_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 6664_UP | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4164_DN | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6746_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 4132_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6500_DN | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 3803_UP | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; HL60; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 3135_UP | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 3995_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 5242_DN | |
| Drug | Bacitracin [1405-87-4]; Up 200; 2.8uM; HL60; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 3109_UP | |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 4196_UP | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6460_UP | |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 4185_UP | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 5849_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; HL60; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 2176_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 6524_UP | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 4087_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 6687_UP | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 2822_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 4023_UP | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; HL60; HG-U133A | 3.67e-04 | 199 | 39 | 4 | 1771_UP | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 4206_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 6466_UP | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 5093_UP | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 3306_UP | |
| Disease | Complement deficiency disease | 9.65e-06 | 33 | 37 | 3 | C0272242 | |
| Disease | dementia (is_implicated_in) | 1.00e-04 | 12 | 37 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.38e-04 | 14 | 37 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 2.06e-04 | 17 | 37 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 2.06e-04 | 17 | 37 | 2 | C0003257 | |
| Disease | Immunologic Deficiency Syndromes | 3.81e-04 | 23 | 37 | 2 | C0021051 | |
| Disease | Alzheimer's disease (is_implicated_in) | 6.08e-04 | 132 | 37 | 3 | DOID:10652 (is_implicated_in) | |
| Disease | pack-years measurement, systolic blood pressure | 8.37e-04 | 34 | 37 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.06e-03 | 160 | 37 | 3 | DOID:5844 (biomarker_via_orthology) | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 1.60e-03 | 47 | 37 | 2 | EFO_0003892, EFO_0004713, EFO_0005671 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CENSAGEEEDEEEET | 156 | Q9BYV9 | |
| CLDGSDEDDCEDVRA | 121 | P07357 | |
| DEDDCEDVRAIDEDC | 126 | P07357 | |
| DGEECDCGEEEECNN | 426 | Q9H013 | |
| DACDDDDDNDGVPDS | 466 | P49747 | |
| GEAEEADESSEEEDC | 516 | Q14692 | |
| NESDSDDLDDEDFEC | 501 | O95905 | |
| LQDCSALCEEEEDED | 136 | Q9NT62 | |
| ALCCDDEEGDGEQEV | 196 | Q2T9L4 | |
| FDEDEECSEEDSGAE | 11 | Q9Y4X5 | |
| DSQDDCGDGSDEENC | 471 | Q9Y561 | |
| CDGDIDCEDQSDEDD | 1116 | Q9NZR2 | |
| DCEDQSDEDDCDSFL | 1121 | Q9NZR2 | |
| CNGQDDCGDEEDERD | 3416 | Q9NZR2 | |
| DCGDEEDERDCPENS | 3421 | Q9NZR2 | |
| CDEDPDCADASDEAN | 3456 | Q9NZR2 | |
| DGDNDCEDNSDEENC | 1126 | Q07954 | |
| DYDNDCGDNSDEESC | 3556 | Q07954 | |
| EDDCGDNSDENPEEC | 3676 | Q07954 | |
| RACSAACSEEEDEED | 461 | Q13387 | |
| EEATECGENCSFEDD | 621 | O60462 | |
| VCDQDQDCDDGSDER | 86 | P98164 | |
| LSCCQEEDEDDETEE | 396 | Q9UNX9 | |
| QDIDECADSEACGEA | 196 | Q14393 | |
| LVCNGDSDCDEDSAD | 101 | P10643 | |
| DSDCDEDSADEDRCE | 106 | P10643 | |
| GDEDCKDGSDEENCS | 401 | Q9Y5Q5 | |
| DDDSDEENCGCKERD | 606 | Q9Y5Q5 | |
| NTAGSECEDVDECEN | 786 | Q8N2S1 | |
| GDNDCGDFSDEDDCE | 121 | P02748 | |
| DDDCDDDDDDDAQIL | 116 | Q6PGQ1 | |
| CLPRSEDDDCDDDDD | 156 | Q6PGQ1 | |
| CDEDDDCLDHSDEDD | 66 | Q14114 | |
| EDDEDADNDDNSGCS | 96 | Q8N108 | |
| DAEDAEDEDCEDGEA | 16 | Q9NZT2 | |
| DRELNEDDSTDCDDD | 626 | Q8WU17 | |
| LCDNQDDCGDGSDEE | 1396 | A2VEC9 | |
| DQEEDCADGSDERGC | 1586 | A2VEC9 | |
| KDGIGDECDDDDDND | 656 | P35443 | |
| DACDDDDDNDKIPDD | 736 | P07996 | |
| VEEEADSCFGDDEDD | 216 | P49427 | |
| EASDCDEFEDDEGAV | 136 | Q14159 | |
| EDCSDGSDEKDCDCG | 591 | Q9Y5Y6 | |
| NPECDDQEDCSDGSD | 171 | Q7Z410 | |
| DQEDCSDGSDEAHCE | 176 | Q7Z410 | |
| DEEEDDDGCDLFADS | 251 | Q9Y4E1 | |
| DEEEDDDGCDLFADS | 251 | Q641Q2 | |
| DCCSRDENEEEEGDS | 521 | Q14679 | |
| VCDDDADCSDQSDES | 211 | P98155 | |
| DGDNDCEDDSDEQDC | 91 | O75096 | |
| DGDADCDDQSDERNC | 251 | O75096 | |
| GEDDCADNSDEENCE | 291 | O75096 | |
| AGAALACCSEDEEDD | 31 | Q147X3 | |
| ACCSEDEEDDEEHEG | 36 | Q147X3 |